FDA-Approved Intralipid Can Protect Hearts Against Ischemic Reperfusion Injury: An Integrated Cellular and Functional Cardiac MRI Study

Keywords

accumulation acute addition administration adverse already although anatomical animal animals anterior approved arrowheads arrows artery assessed atrophy beneficial biological biomedical blood blue bolus cardiac cause caused cell cellular cine circulation clinical composition confirmed coronary days death decreased derived descending detected developing diastole disease dotted dynamic emulsion even exhibit exhibited expansion extent failure flow function functional gadolinium global goal greatly harvest harvested heart hearts histological hour immune in vivo indicate indicating infarct infarction infiltration inflammation injury insults integrated intravenous isotropic labeled lateral limited loss macrophages male measured microscopy model mortality mostly motion much myocardial myocardium occlusion open oxide particles pass percentage perfusion peripheral post preserve preserved prevent prior procedure protect protective rats reduce reduced regional remodeling resolution response restoration rodent sciences site situ spots staining status stop strain strains subjected successful supplement surgical systemic systole systolic tagging temporal therapeutic thinning timely tissue transient treated treatment treatments triggers untreated wall week weeks whereas white zone